235 related articles for article (PubMed ID: 21871086)
1. Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: etiology and prognostic factors.
Chiang HH; Hung CC; Lee CM; Chen HY; Chen MY; Sheng WH; Hsieh SM; Sun HY; Ho CC; Yu CJ
Crit Care; 2011 Aug; 15(4):R202. PubMed ID: 21871086
[TBL] [Abstract][Full Text] [Related]
2. Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy.
Adlakha A; Pavlou M; Walker DA; Copas AJ; Dufty N; Batson S; Edwards SG; Singer M; Miller RF
Int J STD AIDS; 2011 Sep; 22(9):498-504. PubMed ID: 21890545
[TBL] [Abstract][Full Text] [Related]
3. Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy.
Dickson SJ; Batson S; Copas AJ; Edwards SG; Singer M; Miller RF
Thorax; 2007 Nov; 62(11):964-8. PubMed ID: 17517829
[TBL] [Abstract][Full Text] [Related]
4. Predictors of short- and long-term survival in HIV-infected patients admitted to the ICU.
Casalino E; Mendoza-Sassi G; Wolff M; Bédos JP; Gaudebout C; Regnier B; Vachon F
Chest; 1998 Feb; 113(2):421-9. PubMed ID: 9498962
[TBL] [Abstract][Full Text] [Related]
5. Early antiretroviral therapy for HIV-infected patients admitted to an intensive care unit (EARTH-ICU): A randomized clinical trial.
Boniatti MM; Pellegrini JAS; Marques LS; John JF; Marin LG; Maito LRDM; Lisboa TC; Damiani LP; Falci DR
PLoS One; 2020; 15(9):e0239452. PubMed ID: 32956419
[TBL] [Abstract][Full Text] [Related]
6. Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit.
Croda J; Croda MG; Neves A; De Sousa dos Santos S
Crit Care Med; 2009 May; 37(5):1605-11. PubMed ID: 19325488
[TBL] [Abstract][Full Text] [Related]
7. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit.
Casalino E; Wolff M; Ravaud P; Choquet C; Bruneel F; Regnier B
AIDS; 2004 Jul; 18(10):1429-33. PubMed ID: 15199319
[TBL] [Abstract][Full Text] [Related]
8. Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era.
Coquet I; Pavie J; Palmer P; Barbier F; Legriel S; Mayaux J; Molina JM; Schlemmer B; Azoulay E
Crit Care; 2010; 14(3):R107. PubMed ID: 20534139
[TBL] [Abstract][Full Text] [Related]
9. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit.
Palacios R; Hidalgo A; Reina C; de la Torre M; Márquez M; Santos J
HIV Med; 2006 Apr; 7(3):193-6. PubMed ID: 16494634
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era.
Vincent B; Timsit JF; Auburtin M; Schortgen F; Bouadma L; Wolff M; Regnier B
Intensive Care Med; 2004 May; 30(5):859-66. PubMed ID: 14767592
[TBL] [Abstract][Full Text] [Related]
11. Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy.
Greenberg JA; Lennox JL; Martin GS
J Crit Care; 2012 Feb; 27(1):51-7. PubMed ID: 22033058
[TBL] [Abstract][Full Text] [Related]
12. The changing epidemiology of HIV-infected patients in the intensive care unit.
Akgün KM; Pisani M; Crothers K
J Intensive Care Med; 2011; 26(3):151-64. PubMed ID: 21436170
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and Outcomes of HIV-Infected Patients With Severe Sepsis: Continued Risk in the Post-Highly Active Antiretroviral Therapy Era.
Cribbs SK; Tse C; Andrews J; Shenvi N; Martin GS
Crit Care Med; 2015 Aug; 43(8):1638-45. PubMed ID: 25853590
[TBL] [Abstract][Full Text] [Related]
14. Clinical course, prognostic factors, and outcome prediction for HIV patients in the ICU. The PIP (Pulmonary complications, ICU support, and prognostic factors in hospitalized patients with HIV) study.
Afessa B; Green B
Chest; 2000 Jul; 118(1):138-45. PubMed ID: 10893371
[TBL] [Abstract][Full Text] [Related]
15. Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Khouli H; Afrasiabi A; Shibli M; Hajal R; Barrett CR; Homel P
J Intensive Care Med; 2005; 20(6):327-33. PubMed ID: 16280405
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and outcome of HIV-infected patients admitted to the ICU in the current highly active antiretroviral therapy era.
Vidal-Cortés P; Álvarez-Rocha LA; Fernández-Ugidos P; Pérez-Veloso MA; Suárez-Paul IM; Virgós-Pedreira A; Pértega-Díaz S; Castro-Iglesias ÁC
Med Intensiva (Engl Ed); 2020; 44(5):283-293. PubMed ID: 30971339
[TBL] [Abstract][Full Text] [Related]
17. Short- and medium-term prognosis of HIV-infected patients receiving intensive care: a Brazilian multicentre prospective cohort study.
Andrade HB; da Silva I; Ramos GV; Medeiros DM; Ho YL; de Carvalho FB; Bozza FA; Japiassú AM
HIV Med; 2020 Nov; 21(10):650-658. PubMed ID: 32876389
[TBL] [Abstract][Full Text] [Related]
18. Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era.
Akgün KM; Tate JP; Pisani M; Fried T; Butt AA; Gibert CL; Huang L; Rodriguez-Barradas MC; Rimland D; Justice AC; Crothers K
Crit Care Med; 2013 Jun; 41(6):1458-67. PubMed ID: 23507717
[TBL] [Abstract][Full Text] [Related]
19. Short- and long-term outcome of HIV-infected patients admitted to the intensive care unit.
van Lelyveld SF; Wind CM; Mudrikova T; van Leeuwen HJ; de Lange DW; Hoepelman AI
Eur J Clin Microbiol Infect Dis; 2011 Sep; 30(9):1085-93. PubMed ID: 21331480
[TBL] [Abstract][Full Text] [Related]
20. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005.
Yang CH; Huang YF; Hsiao CF; Yeh YL; Liou HR; Hung CC; Yang SY
HIV Med; 2008 Aug; 9(7):535-43. PubMed ID: 18554309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
